Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients
1 other identifier
observational
N/A
1 country
1
Brief Summary
Organ transplant patients and staff members at the Transplant Institute have received pandemic H1N1 influenza vaccine (Pandemrix) and specific antibody production was measured by haemagglutination inhibition according to the clinical guidelines and policy, respectively. This study retrospectively assessed the immune response after vaccination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 6, 2010
CompletedFirst Posted
Study publicly available on registry
December 7, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedJanuary 16, 2012
January 1, 2012
1.3 years
December 6, 2010
January 13, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of responders in organ transplant patients and controls
Secondary Outcomes (1)
Frequency of >4-fold titre rise in organ transplant patients and controls
Study Arms (2)
organ transplant patients
healthy controls
Interventions
Eligibility Criteria
Tranplant patients at the out-patient clinical ward and staff members at the Transplant Institute, Sahlgrenska University Hospital.
You may qualify if:
- Cohort number 1:Organ transplant patients who were vaccinated and serum sample drawn at baseline.
- Cohort number 2: Staff members who were vaccinated and serum sample drawn at baseline.
You may not qualify if:
- Cohort number 1: Organ transplant patients who were vaccinated and no serum sample drawn at baseline.
- Cohort number 2: Staff members who were vaccinated and no serum sample drawn at baseline.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Transplant Institute, Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, 413 45, Sweden
Related Publications (1)
Felldin M, Studahl M, Svennerholm B, Friman V. The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients. Transpl Int. 2012 Feb;25(2):166-71. doi: 10.1111/j.1432-2277.2011.01391.x. Epub 2011 Nov 26.
PMID: 22117586RESULT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
December 6, 2010
First Posted
December 7, 2010
Study Start
October 1, 2009
Primary Completion
January 1, 2011
Study Completion
August 1, 2011
Last Updated
January 16, 2012
Record last verified: 2012-01